News Archive

Florida Atlantic University's Stiles-Nicholson Brain Institute will celebrate advancements in brain science and health with its annual "Brainy Days" events throughout the month of March.

FAU researchers have developed cutting-edge fluorescent cholesterol probes, which now enable them to visualize cholesterol movement and distribution in live cells with unprecedented detail.

FAU neuroscientists have identified that the receptor IL-1R1 plays a critical role in enabling neurons to directly communicate with the immune system.

Randy D. Blakely, Ph.D., a highly regarded neuroscientist and pharmacologist, is among an extraordinary group selected by the American Society for Pharmacology and Experimental Therapeutics.

FAU has added a new state-of-the-art MRI system to its research infrastructure, marking a transformative step forward for groundbreaking studies in neuroscience, clinical health and medical advancements.

A groundbreaking study by FAU researchers using a tiny roundworm, links the worm gene swip-10 to copper regulation, which could pave the way for new treatments for neurodegenerative disorders.

Florida Atlantic University has been ranked No. 41 overall among the nation's best public and private universities by Washington Monthly.

With the help of a tiny, transparent worm, FAU researchers have identified novel players in dopamine signaling by taking advantage of a powerful platform generated via the Million Mutation Project (MMP).

"Fit2Drive," an algorithm developed by FAU researchers has made it easy to administer and evaluate an in-office test to predict an older individual's probability of passing an on-road driving test.

The summit brought together leading scientists in the field across North America and Europe to discuss the latest research and advancements in the study of amyloid-related diseases.